Medicare Enrolled
Dr. Peter Ennis, M.D.
Hematology & Oncology · Broomall, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ennis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ennis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ennis
Dr. Peter Ennis is a hematology & oncology specialist in Broomall, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ennis performed 34,853 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ennis received a total of $5,532 from 69 pharmaceutical and/or device companies across 289 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ennis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 14% volume in PA
$5,532 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗34,853
Medicare services
Top 14% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
15,010 | $2 | $21 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
12,240 | $0 | $6 |
| Iron infusion (Monoferric) | 2,500 | $17 | $74 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,434 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
783 | $7 | $30 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
600 | $8 | $19 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
289 | $143 | $301 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
286 | $98 | $224 |
| Anti-nausea injection (Aloxi/palonosetron) | 250 | $1 | $122 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
201 | $66 | $148 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
185 | $99 | $232 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
157 | $11 | $93 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
143 | $24 | $152 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
139 | $1 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
105 | $112 | $686 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
94 | $53 | $304 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
90 | $59 | $205 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
81 | $4 | $20 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
60 | $11 | $73 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
47 | $56 | $334 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
46 | $146 | $411 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
38 | $1 | $19 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
36 | $13 | $105 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
26 | $16 | $20 |
| New patient office visit, complex (60-74 min) | 13 | $179 | $432 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
43.4% high complexity
48.8% medium
7.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,532
Total received (2018-2024)
Avg $790/year across 7 years
Top 32% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
289
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$857
2023
$972
2022
$387
2021
$287
2020
$487
2019
$1,500
2018
$1,043
Payments by company (2024)
PFIZER INC.
$138
ABBVIE INC.
$94
Celgene Corporation
$86
GENZYME CORPORATION
$60
Incyte Corporation
$47
Merck Sharp & Dohme LLC
$39
AstraZeneca Pharmaceuticals LP
$36
Sumitomo Pharma America, Inc.
$35
Blueprint Medicines Corporation
$28
Amneal Pharmaceuticals LLC
$26
Genentech USA, Inc.
$25
Genmab U.S., Inc.
$25
Stemline Therapeutics Inc.
$24
Eisai Inc.
$23
Janssen Biotech, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
ADC Therapeutics America, Inc.
$20
SOBI, INC
$19
SpringWorks Therapeutics, Inc.
$19
Mirati Therapeutics, Inc.
$18
ARRAY BIOPHARMA INC
$17
Novartis Pharmaceuticals Corporation
$17
Top 3 companies account for 37.2% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$854
Celgene Corporation
$374
PFIZER INC.
$350
AstraZeneca Pharmaceuticals LP
$271
Novartis Pharmaceuticals Corporation
$269
Pharmacyclics LLC, An AbbVie Company
$226
GENZYME CORPORATION
$223
Genentech USA, Inc.
$202
Servier Pharmaceuticals LLC
$159
Merck Sharp & Dohme Corporation
$150
Janssen Biotech, Inc.
$144
ABBVIE INC.
$130
Akcea Therapeutics, Inc.
$125
Amgen Inc.
$117
Daiichi Sankyo Inc.
$107
Merck Sharp & Dohme LLC
$95
Blueprint Medicines Corporation
$90
Takeda Pharmaceuticals U.S.A., Inc.
$90
Incyte Corporation
$84
Astellas Pharma US Inc
$76
Regeneron Healthcare Solutions, Inc.
$67
Kite Pharma, Inc.
$66
Bayer Healthcare Pharmaceuticals Inc.
$58
JAZZ PHARMACEUTICALS INC.
$57
Seattle Genetics, Inc.
$51
Jazz Pharmaceuticals Inc.
$49
Gilead Sciences, Inc.
$47
Eisai Inc.
$45
Lilly USA, LLC
$44
Seagen Inc.
$44
Teva Pharmaceuticals USA, Inc.
$39
Karyopharm Therapeutics Inc.
$38
Puma Biotechnology, Inc.
$36
ADC Therapeutics America, Inc.
$36
Sumitomo Pharma America, Inc.
$35
GlaxoSmithKline, LLC.
$35
TerSera Therapeutics LLC
$33
EMD Serono, Inc.
$32
Exelixis Inc.
$30
AMAG Pharmaceuticals, Inc.
$30
AVEO Pharmaceuticals, Inc.
$27
Amneal Pharmaceuticals LLC
$26
Spectrum Pharmaceuticals Inc.
$25
Janssen Pharmaceuticals, Inc
$25
Genmab U.S., Inc.
$25
Stemline Therapeutics Inc.
$24
MorphoSys, US Inc.
$23
Verastem, Inc.
$22
Ipsen Biopharmaceuticals, Inc
$20
SOBI, INC
$19
SANOFI-AVENTIS U.S. LLC
$19
SpringWorks Therapeutics, Inc.
$19
Mirati Therapeutics, Inc.
$18
Rigel Pharmaceuticals, Inc.
$17
ARRAY BIOPHARMA INC
$17
Mylan Institutional Inc.
$17
AbbVie, Inc.
$17
Sirtex Medical Inc
$17
Clovis Oncology, Inc.
$16
Tactile Systems Technology Inc
$15
Lexicon Pharmaceuticals, Inc.
$14
EISAI INC.
$14
Advanced Accelerator Applications
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
Alexion Pharmaceuticals, Inc.
$13
INSYS Therapeutics Inc
$12
Prometheus Laboratories Inc.
$12
Midatech Pharma US Inc
$12
Aurobindo Pharma USA, Inc.
$11
Top 3 companies account for 28.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · AVASTIN · AYVAKIT · Abraxane · Alecensa · BENDEKA · BOSULIF · Balversa · Bavencio · CALQUENCE · CAMZYOS · Cabometyx · Copiktra · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · Enhertu · Epkinly · Erleada · FERAHEME · FLEXITOUCH · FOTIVDA · Folotyn · Fulphila · Gelclair · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Idhifa · Imbruvica · Inrebic · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · MVASI · MYLOTARG · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OPDIVO · ORGOVYX · Orserdu · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Padcev · Pomalyst · Proleukin · REBLOZYL · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TEGSEDI · TIBSOVO · TUKYSA · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Venclexta · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEPZELCA · ZOLADEX · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
272
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
BRYN MAWR HOSPITAL
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ennis is a mixed practice specialist, with above-average Medicare volume (top 14% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ennis experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Ennis performed 15,010 darbepoetin injection (aranesp) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ennis receive payments from pharmaceutical companies?
Yes. Dr. Ennis received a total of $5,532 from 69 companies across 289 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ennis's costs compare to other hematology & oncology specialists in Broomall?
Dr. Ennis's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ennis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Broomall
Browse hematology & oncology specialists in Broomall ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology